2m 2m 2m 2m 2m 2m 2m
Axsome Therapeut (AXSM)
NASDAQ
$206.91-$0.86 (-0.41%)
Price as of Aug 21, 2026 7:32 PM EDT- $10.9BMarket Cap
- 75.32%1-Year Change
- BiotechnologyIndustry
Axsome Therapeut (AXSM)
$206.91-$0.86 (-0.41%)
AXSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $207.77 | ||
Change | -$0.26 (-0.12%) | ||
Open | $207.22 | ||
High | $210.87 | ||
Low | $206.50 | ||
Previous Close | $208.03 | ||
Volume | 734,951 | ||
30-Day Average Volume | 692,664 | ||
1-Week Change | -2.76% | ||
1-Month Change | -12.31% | ||
1-Year Change | 75.32% | ||
3-Year Change | 191.93% | ||
5-Year Change | 863.68% | ||
Fundamentals | |||
Shares Outstanding | 52.4M | ||
Total Assets | $761.4M | ||
Market Cap | $10.9B | ||
Enterprise Value | $10.8B | ||
Period: QTR TTM FY | |||
Revenue | $216.4M | ||
Net Income | -$51.3M | ||
Free Cash Flow | -$33.4M | ||
EBIT | -$48.0M | ||
EBITDA | -$46.4M | ||
Net Working Capital | $196.1M | ||
EPS | -$0.99 | ||
Enterprise Value/EBITDA | -232 | ||
Enterprise Value/Revenue | 50 | ||
P/B | 131 | ||
P/E | -210 | ||
PEG | -10 | ||
Price/Free Cash Flow | -326 | ||
Price/Operating Cash Flow | -330 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue